Download video

A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML

77 views

VJHemOnc – Video Journal of Hematology & HemOnc

5 years ago

A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML

A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML

Venetoclax in RR CLL
3:13
Venetoclax in RR CLL
by OncLive
How can venetoclax combinations improve outcome for FLT3-mutant AML?
6:46
How can venetoclax combinations improve outcome for FLT3-mutant AML?
by AML Hub
How effective is Venetoclax? #AML
15:13
How effective is Venetoclax? #AML
by HealthTree University for Blood Cancers
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
4:27
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Combining venetoclax with CPX-351 for AML
5:03
Combining venetoclax with CPX-351 for AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Midostaurin: a step forward in the treatment of FLT3-mutated AML
0:59
Midostaurin: a step forward in the treatment of FLT3-mutated AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
γ9δ2 T-cell activation with ICT01 and azacitidine-venetoclax in patients with newly diagnosed AML
6:45
γ9δ2 T-cell activation with ICT01 and azacitidine-venetoclax in patients with newly diagnosed AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Anti-tumor Effect of Antibody Drug With Venetoclax Plus Azacitidine in AML | Oncotarget
2:20
Anti-tumor Effect of Antibody Drug With Venetoclax Plus Azacitidine in AML | Oncotarget
by Oncotarget
Hot topics in AML from EHA 2025: menin inhibitors, adjusting venetoclax dose, \& maintenance therapy
4:47
Hot topics in AML from EHA 2025: menin inhibitors, adjusting venetoclax dose, \& maintenance therapy
by VJHemOnc – Video Journal of Hematology \& HemOnc
Comparison of venetoclax-based versus non-venetoclax-based treatment regimens in AML
7:55
Comparison of venetoclax-based versus non-venetoclax-based treatment regimens in AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Is venetoclax a game changer in AML therapy?
2:26
Is venetoclax a game changer in AML therapy?
by VJHemOnc – Video Journal of Hematology \& HemOnc
Venetoclax for AML
4:03
Venetoclax for AML
by OncLive
Optimal Use of Venetoclax in AML
3:12
Optimal Use of Venetoclax in AML
by OncLive
Cancer Supplement Tactic™: Vitamin K2 and Cancer
0:57
Cancer Supplement Tactic™: Vitamin K2 and Cancer
by Keith Bishop Prevail Over Cancer
Venetoclax in AML
5:30
Venetoclax in AML
by OncLive
ABT199\/Venetoclax Synergism with Thiotepa Enhances AML Cytotoxicity | Oncotarget
2:03
ABT199\/Venetoclax Synergism with Thiotepa Enhances AML Cytotoxicity | Oncotarget
by Oncotarget
Venetoclax plus azacitidine in FLT3-mutated AML
1:48
Venetoclax plus azacitidine in FLT3-mutated AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Venetoclax-Based Chemotherapy Combinations in AML
3:45
Venetoclax-Based Chemotherapy Combinations in AML
by OncLive
Venetoclax combination therapies in AML
1:18
Venetoclax combination therapies in AML
by VJHemOnc – Video Journal of Hematology \& HemOnc